Louisiana 2023 Regular Session

Louisiana Senate Bill SB171

Introduced
3/31/23  
Refer
3/31/23  
Refer
4/10/23  
Report Pass
4/18/23  
Report Pass
4/18/23  
Engrossed
5/3/23  
Refer
5/4/23  
Refer
5/4/23  

Caption

Creates the pharmacy benefit managers quality incentive program. (gov sig) (RE1 SG EX See Note)

Impact

The proposed legislation emphasizes the creation of a structured framework for achieving better healthcare outcomes by rewarding pharmacies that actively engage in improving patient health. PBMs are required to report annually on their incentive programs, detailing their implementations and results. By facilitating this relationship through a quality incentive program, the bill aims to not only promote medication adherence but also potentially lower healthcare costs by reducing emergency visits related to untreated health conditions.

Summary

Senate Bill 171, introduced by Senator Fred Mills, establishes a pharmacy benefit manager (PBM) quality incentive program aimed at improving the health outcomes of Louisiana residents. This program mandates PBMs to develop incentive payment systems for eligible independent pharmacies that comply with health improvement strategies. The focus is on addressing prevalent health issues in Louisiana, such as chronic diseases and medication adherence. The intention is to enhance collaborations between PBMs and local pharmacies, ensuring that patient care and health education become integral components of pharmacy services across the state.

Sentiment

General sentiment around SB 171 leans toward positivity, as it is perceived as a proactive measure in addressing serious health disparities faced by Louisiana residents. Proponents of the bill, including various healthcare advocates, believe it will create better healthcare access and improve community health. Nevertheless, while there appears to be a consensus on the necessity of improving health outcomes, concerns may arise regarding the implementation specifics and the extent to which independent pharmacies would be compelled to participate in the program.

Contention

One notable point of contention lies in the voluntary nature of the incentive program. Although it is framed to encourage participation without penalties for declining, there may be worries regarding whether participation remains truly optional for smaller pharmacies. Additionally, the exemption of Medicaid managed care organization PBMs from the proposed law could lead to disparities in how various entities are regulated under the new system, prompting questions about fairness in health resource distribution and access across Louisiana's diverse healthcare landscape.

Companion Bills

No companion bills found.

Similar Bills

LA HB704

Creates the pharmacy benefit managers quality incentive program (RE SEE FISC NOTE SG RV See Note)

LA SB41

Provides relative to the regulation of pharmacy benefit managers. (See Act) (EN INCREASE SG EX See Note)

LA SB83

Creates the Council on Medicaid Pharmacy Reimbursement. (8/1/22) (EN NO IMPACT See Note)

LA SB283

Provides relative to pharmacy benefit managers. (See Act) (EN NO IMPACT See Note)

LA HB436

Provides for insurance reimbursement of certain provider fees paid by pharmacies (EN SEE FISC NOTE GF EX See Note)

LA SB117

Provides for the Medicaid Pharmaceutical and Therapeutics Committee.

LA SB48

Provides relative to Medicaid pharmacy services. (8/1/19)

LA SB130

Provides relative to contracts for Medicaid pharmacy benefit management services. (8/1/18)